Friday, April 23, 2021 COVID-19 Vaccine Responses to be Studied in People with Immune Deficits A study assessing how people with immune system deficiencies or dysregulations respond to COVID-19 vaccination has begun enrolling participants at the National Institutes of Health Clinical Center in Bethesda, Maryland. The single-site study is led by researchers from the National Institute of Allergy and Infectious Diseases and aims to enroll 500 people, 400 of whom have primary or secondary immune system disorders and 100 without such conditions. All study visits can be conducted either in person or remotely. Participants may be enrolled if they are completely or partially vaccinated against COVID-19 or if they have not yet been vaccinated. The study team will also gather information about COVID-19 illness in people with immune deficiencies and dysregulation conditions. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107